Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 2: Passive Immunization
Submit an article Journal homepage
3,112
Views
9
CrossRef citations to date
0
Altmetric
Passive SF – Review

Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases

Tharmala Tharmalingama Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, CanadaView further author information
,
Xiaobing Hana Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, Canada;b Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, CanadaView further author information
,
Ashley Wozniaka Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, CanadaView further author information
&
Laura Sawarda Therapeutics Business Unit, Emergent BioSolutions Incorporated, Winnipeg, MB, Canada;c Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, CanadaCorrespondence[email protected]
View further author information
Article: 1886560 | Received 18 Dec 2020, Accepted 01 Feb 2021, Published online: 19 May 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Larry Zeitlin & Richard A. Cone. (2022) Special focus issue: passive immunization. Human Vaccines & Immunotherapeutics 18:2.
Read now

Articles from other publishers (8)

Matthias Germer, Viola Marschall, Veit Braun, Jörg Schüttrumpf & Matthias Germer. (2023) Rising anti-SARS-CoV-2 titer in a human immunoglobulin preparation. International Journal of Blood Transfusion and Immunohematology 13:1, pages 1-8.
Crossref
Gabriele Niemann, Matthias Germer, Matthias Hauf, Gerhard Poelsler, Juliane Röder & Jörg Schüttrumpf. (2023) Hyperimmunplasma: Gewinnung, Verarbeitung und therapeutische Anwendungen. Transfusionsmedizin 13:01, pages 18-29.
Crossref
Coco R. Beudeker, Daniel C. Vijlbrief, Joris M. van Montfrans, Suzan H.M. Rooijakkers & Michiel van der Flier. (2022) Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?. Frontiers in Immunology 13.
Crossref
Aruni Jha, Douglas Barker, Jocelyne Lew, Vinoth Manoharan, Jill van Kessel, Robert Haupt, Derek Toth, Matthew Frieman, Darryl Falzarano & Shantha Kodihalli. (2022) Efficacy of COVID-HIGIV in animal models of SARS-CoV-2 infection. Scientific Reports 12:1.
Crossref
AbdulRahman A. Saied, Manuela Sales Lima Nascimento, Adriano Henrique do Nascimento Rangel, Krzysztof Skowron, Katarzyna Grudlewska‐Buda, Kuldeep Dhama, Jaffer Shah, Ahmed Abdeen, Fouad S. El‐Mayet, Hassan Ahmed & Asmaa A. Metwally. (2022) Transchromosomic bovines‐derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS‐CoV‐2, MERS‐CoV, Ebola, Zika, HIV‐1, and influenza A virus. Journal of Medical Virology 94:10, pages 4599-4610.
Crossref
Xiaobing Han, Roger Ortines, Ipsita Mukherjee, Tulasikumari Kanipakala, Thomas Kort, Shardulendra P. Sherchand, Grant Liao, Mark Mednikov, Agnes L. Chenine, M. Javad Aman, Cory L. Nykiforuk & Rajan P. Adhikari. (2022) Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models. Frontiers in Immunology 13.
Crossref
William R. Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F. Carroll, Bruce A. Keyt & Lila M. Strohl. (2022) Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants. BioDrugs 36:3, pages 231-323.
Crossref
Abdul Hawil Abas, Siti Marfuah, Rinaldi Idroes, Diah Kusumawaty, Fatimawali, Moon Nyeo Park, Abolghasem Siyadatpanah, Fahad A. Alhumaydhi, Shafi Mahmud, Trina Ekawati Tallei, Talha Bin Emran & Bonglee Kim. (2022) Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?. Molecules 27:7, pages 2221.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.